-
www.ahrq.gov/evidencenow/heart-health/cholesterol/algorithm.html
September 01, 2018 - Cholesterol Management Treatment Algorithm
Resource title: Heart Health NOW! Lipid Algorithm
Resource description: This decision tree summarizes recommendations for prescribing statins in primary and secondary treatment of cardiovascular disease.
Document author(s)/institution of origin: University of No…
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/outreach.html
September 01, 2018 - Automated Outreach & Adherence to Cholesterol-Lowering Medication
Resource title: Automated Outreach to Increase Primary Adherence to Cholesterol-Lowering Medications .
Resource description: This journal article summarizes findings from a randomized controlled trial that evaluated an automated system for im…
-
www.ahrq.gov/evidencenow/heart-health/cholesterol/detailing.html
September 01, 2018 - Cholesterol Management Academic Detailing Guide for Practices
Resource title: Cholesterol Management in Primary Care
Resource description: This facts-at-a-glance handout for clinicians summarizes guidelines for prescribing statins for cholesterol management in high-risk groups, including patients with prior…
-
www.ahrq.gov/sites/default/files/2024-02/whitney-report.pdf
January 01, 2024 - Effects of
Informed Consent on Statin Therapy Decision Making: Preliminary Pilot Study
Results. … Effects of a Statin
Decision Aid on Explanatory Models and Shared Decision Making. … Effect of
Informed Consent on Compliance With Statin Therapy: A Pilot Study.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/d4n_combo_iqi-mortalityreview-bestpractices.pdf
May 20, 2016 - • Beta blocker, statin, ACE inhibitor/ARB (if EF<40%) at discharge. … Thrombolytic Therapy
• STK-5 Antithrombotic Therapy By End of Hospital Day 2
• STK-6 Discharged on Statin … • Beta blocker, statin, ACE inhibitor/ARB (if EF<40%) at discharge.
References
1.
-
www.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/north-carolina.html
March 01, 2021 - Up to 80 percent improved on statin therapy.
-
www.ahrq.gov/evidencenow/projects/heart-health/about/stories/in-action/east-asheville.html
March 01, 2021 - That led to 230 of those patients being prescribed a statin and 368 an aspirin—two of the four ABCS of
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm8c.html
October 01, 2014 - Randomized controlled trial of an informatics-based intervention to increase statin prescription for
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/chcanys-qi-primer.pdf
August 01, 2017 - Cholesterol
management
Percent of patients 21 and older
diagnosed with ASCVD who are
on statin therapy … + Percent of
patients 21 and older with
history of LDL ≥ 190mg/dL who
are on statin therapy + Percent … of patients 40-75 with diabetes
who are on statin therapy
To determine if statin therapy for
prevention … and treatment of CVD is
being prescribed for those in the
1st, 2nd, and 3rd statin benefit groups. … This composite score shows total statin
use in those that may most benefit.
-
www.ahrq.gov/evidencenow/projects/heart-health/research-results/research/methods/measures.html
August 01, 2018 - Percentage of patients with IVD, diabetes mellitus (DM), or low-density lipoprotein (LDL) > 190 receiving a statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-nc.pdf
November 01, 2017 - • Up to 80 percent improved on statin therapy.
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/cvd-risk-calculator.pdf
February 01, 2022 - are calculated, clinicians need to
communicate the risk clearly, along with the benefits
(e.g., statin … Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task
-
www.ahrq.gov/data/infographics/index.html
July 01, 2025 - District of Columbia Across All Health Care Quality Measures Increased Newborn and Mother Hospital Stays Statin
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
November 29, 2004 - patients on fibrate 4 with CK > 3x upper limit of
normal
0.7% 0.1%
388 patients on fibrate plus
statin
-
www.ahrq.gov/evidencenow/projects/heart-health/research-results/results/publications.html
May 01, 2024 - The authors found no record of moderate- to high-intensity statin prescription among 43% of participating … female sex, and lower low-density lipoprotein cholesterol were associated with a lack of appropriate statin … Additionally, lack of appropriate statin intensity was higher in independent practices than in Federally … A Cohort Analysis of Statin Treatment Patterns Among Small-Sized Primary Care Practices. … Therapy Clinical Quality Measure In the Northwest Cooperative’s development of a statin therapy clinical
-
www.ahrq.gov/sites/default/files/2024-07/oconnor-report.pdf
January 01, 2024 - mg/dL, or ALT > 4x normal; (2) use of TZDs in
patient with CHF or ALT > 2.5x normal, (3) use of a statin … in a patient with ALT > 4x normal, or (4) use of
both statin and fibrate in a patient with CPK > 2x … Cholesterol levels and statin use in patients with coronary
heart disease treated in primary care settings … T1: high ALT/AST in 12 months and on statin. No pre-intervention errors. … X8: On statin and high CK
pre-intervention errors N 10 4 4 1 1
post-intervention resolved (%) 40.0 75.0
-
www.ahrq.gov/sites/default/files/2024-02/gandhi-report.pdf
January 01, 2024 - Reminders and Guidelines: CAD and elevated LDL—
measure LDL if not measured, and start or increase statin … Chronic Disease Management Reminders and Guidelines: DM and elevated LDL—start
or increase statin
α/ … dysfunction
• Elevated potassium and taking a med that may raise potassium
• Elevated ALT and taking a statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/recruitment-slides-ny.pdf
August 18, 2015 - through 79 years of age who
had a LDL test performed and who are prescribed a
recommended dose of statin
-
www.ahrq.gov/sites/default/files/2024-07/samore-report.pdf
January 01, 2024 - Drug-drug interactions: Overall, 148 coumadin-associated potential drug-drug interactions
(DDI), 43 statin-associated … person-months
Overall rate Range Overall rate Range across
clinics
Coumadin DDI 5.5 2.3-20.0 16.3 8.7-29.5
Statin … 100 person-months
Overall rate Range rate Overall rate Range
Coumadin DDI 9.9 5.1-26.5 12.9 1.7-18.6
Statin … Rate ratio calculated as post CCOE/pre CCOE
Rate ratio Range rate ratio
Coumadin DDI 1.1 0.4-11.7
Statin
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-part1-mw.pdf
June 02, 2025 - practice uses clinical guidelines for management of patients at risk for
cardiovascular disease (e.g., statin